Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.
暂无分享,去创建一个
Xian Chen | Jing Wang | K. Hunt | K. Keyomarsi | K. Mikule | J. Litton | S. Vijayaraghavan | Yang Zhao | J. P. Carey | Cansu Karakas | Tuyen N Bui | J. Carey